# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Acute myeloid leukemia

Acute Non Lymphoblastic Leukemia
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 11-20 of 630 results.
Exploring Disease Immunogenicity and the Immunological Effects of Hypomethylating Agents in Acute Myeloid Leukemia
Status: Not yet recruiting
Last Changed: Feb 27, 2019
First Received: Dec 31, 2018
Disease(s): Acute Myeloid Leukemia
Intervention(s): Immunogenic profile
Locations: Policlinico S.Orsola-Malpighi, Bologna, BO, Italy
AO Spedali Civili di Brescia, Brescia, BS, Italy
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Meldola, FC, Italy
IRCCS AOU S. Martino Genova, Genova, GE, Italy
Irccs Crob, Rionero in Vulture, PZ, Italy
... and 6 other locations.
Micro-transplantation in Elderly Patients With Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Apr 26, 2019
First Received: Feb 20, 2018
Disease(s): Acute Myeloid Leukemia
Intervention(s): HLA-mismatched micro-transplantation after induction chemotherapy
Locations: CHU Estaing, Clermont-Ferrand, France
Centre Hospitalier Universitaire de Grenoble, Grenoble, France
Centre Hospitalier Lyon Sud, Lyon, France
Centre Hospitalier Universitaire de Nancy, Nancy, France
Hôpital de la Pitié-Salpêtrière, Paris, France
... and 2 other locations.
Central Nervous System (CNS) Involvement in Acute Myeloid Leukemia (AML)
Status: Not yet recruiting
Last Changed: Oct 15, 2018
First Received: Jan 25, 2018
Disease(s): Acute Myeloid Leukemia
Intervention(s): Observation of CNS involvement
Locations: Dipartimento di Biotecnologie Cellulari ed Ematologia, "Sapienza", Università di Roma, Roma, Italy
The Feasibility of Safely Managing Patients Receiving Induction With Liposomal Daunorubicin and Cytarabine (CPX-351) for Acute Myeloid Leukemia (AML) in an Outpatient Environment
Status: Not yet recruiting
Last Changed: Jun 17, 2019
First Received: Jun 17, 2019
Disease(s): Acute Myeloid Leukemia
Intervention(s): CPX-351
Study to Determine the Efficacy of Uproleselan (GMI-1271) in Combination With Chemotherapy to Treat Relapsed/Refractory Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Aug 05, 2019
First Received: Aug 06, 2018
Disease(s): Acute Myeloid Leukemia
Intervention(s): Uproleselan, Placebo
Locations: UC San Diego Moore Cancer Center, La Jolla, California, United States
UC Davis Comprehensive Cancer Center, Sacramento, California, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Washington University School of Medicine, Saint Louis, Missouri, United States
Roswell Park Cancer Institute, Buffalo, New York, United States
... and 19 other locations.
Screening of IDH1 and IDH2 Gene Mutations in Adult Acute Myeloid Leukemia for Possible Targeted Therapy
Status: Recruiting
Last Changed: Apr 20, 2018
First Received: Apr 17, 2018
Disease(s): Acute Myeloid Leukemia
Locations: National Taiwan University Hospital, Taipei, Taiwan
A Randomized Trial of a Combination of Nintedanib/Placebo in Combination With Induction Chemotherapy for Patients With Refractory or First Relapse Acute Myeloid Leukemia
Status: Recruiting
Last Changed: May 06, 2019
First Received: Jan 27, 2016
Disease(s): Relapsed/Refractory Acute Myeloid Leukemia
Intervention(s): nintedanib and AML induction, AML induction (placebo)
Locations: Yale University, New Haven, Connecticut, United States
Vanderbilt Ingram Cancer Center, Nashville, Tennessee, United States
IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Patients With CD123-Positive Acute Myeloid Leukemia
Status: Not yet recruiting
Last Changed: Sep 11, 2019
First Received: Sep 11, 2019
Disease(s): Acute Myeloid Leukemia
Intervention(s): Azacitidine, IMGN632, Venetoclax
A Study of Venetoclax and Alvocidib in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Apr 22, 2019
First Received: Feb 21, 2018
Disease(s): Acute Myeloid Leukemia (AML)
Intervention(s): Venetoclax, Alvocidib
Locations: USC Norris Cancer Center /ID# 170844, Los Angeles, California, United States
UC Irvine /ID# 201093, Orange, California, United States
UC Davis Comp Cancer Ctr /ID# 170799, Sacramento, California, United States
Sylvester Comprehensive Cancer /ID# 170761, Miami, Florida, United States
Indiana Blood & Marrow Transpl /ID# 170793, Indianapolis, Indiana, United States
... and 11 other locations.
Efficacy and Pharmacogenomics of Salvage CLAG-M Chemotherapy in Patients With Relapse/Refractory and Secondary Acute Myeloid Leukemia
Status: Recruiting
Last Changed: Mar 13, 2019
First Received: May 11, 2017
Disease(s): Acute Myeloid Leukemia
Intervention(s): CLAG-M regimen
Locations: Froedtert & the Medical College of Wisconsin, Milwaukee, Wisconsin, United States